Evidence map›Paper›PMID 32390191›Full record

ArticleThe British journal of dermatology2020

Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.

Y Kim, E Jorgenson, M M Asgari

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Y KimDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.ORCID 0000-0001-8266-6241
E JorgensonKaiser Permanente Northern California, Division of Research, Oakland, CA, USA.
M M AsgariDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

Funding

Patient-oriented research and mentoring program in dermatologic diseasesK24AR069760 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA · 2017 to 2025
$1.9M
The Role of Genetic Risk Factors in Keratinocyte Carcinoma SusceptibilityR01CA241623 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI ASGARI, MARYAM MANDANA, CHOQUET, HELENE · 2020 to 2025
$1.7M
PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progressionR01CA231264 · NCI · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA · 2019 to 2023
$1.5M
NCI NIH HHS R01 CA231264NCI NIH HHS R01 CA241623NIAMS NIH HHS K24 AR069760
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarcinomaKeratosis, ActinicSkin NeoplasmsHumansKeratinocytes

Identifiers

PMID32390191
PMCPMC7720815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.